{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:00:57Z","timestamp":1793894457835,"version":"4.8.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Gulf Coast Consortia","award":["T15LM007093"],"award-info":[{"award-number":["T15LM007093"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS106640"],"award-info":[{"award-number":["R21NS106640"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56AG080920"],"award-info":[{"award-number":["R56AG080920"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infection with SARS-CoV-2, the virus responsible for COVID-19, can lead to a range of physical symptoms and mental health challenges, including stress, anxiety, and depression. These effects are particularly pronounced in hospitalized patients, likely due to the virus\u2019s direct and indirect impact on the nervous system. Gut dysbiosis, an imbalance in the gut microbiome, has been implicated in immune dysfunction and chronic inflammation in COVID-19 patients. However, the interactions between gut microbiome composition and the physical and mental symptoms of COVID-19 remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the association between physical and mental symptoms, cytokine profiles, and gut microbiota composition in 124 hospitalized COVID-19 patients. We collected data on demographics, COVID-19 severity, and mental health indicators (stress, anxiety, and depression). Gut microbiome profiling was performed using full-length 16\u00a0S rRNA gene sequencing to evaluate microbial diversity and composition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      COVID-19 severity was categorized as low (27.4%), moderate (29.8%), or critical (42.8%). Common symptoms included fever (66.1%) and cough (55.6%), while somatic symptoms (27.3%), anxiety (27.3%), depressive symptoms (39%), and stress (80.5%) were frequently self-reported. Elevated interleukin-6 levels in severe cases highlighted systemic inflammation, reduced gut bacterial diversity, particularly among women and obese patients, correlated with higher disease severity. Notably, the genus\n                      <jats:italic>Mitsuokella<\/jats:italic>\n                      was associated with increased physical symptoms and mental distress, while\n                      <jats:italic>Granulicatella<\/jats:italic>\n                      was linked to critical illness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings reveal significant associations between mental health status, systemic inflammation, and gut dysbiosis in hospitalized COVID-19 patients. These results indicate the potential for microbiome-targeted therapies to mitigate psychological and physical complications and improve recovery outcomes in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-025-06348-y","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T06:39:07Z","timestamp":1741934347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Gut Microbiome dysbiosis and immune activation correlate with somatic and neuropsychiatric symptoms in COVID-19 patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Paula L.","family":"Scalzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin G.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirena","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Dulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timea","family":"Hodics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn M. M.","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd J.","family":"Treangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda M.","family":"Piskorz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6174-4113","authenticated-orcid":false,"given":"Sonia","family":"Villapol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"6348_CR1","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1007\/s00415-023-11914-9","volume":"270","author":"AM Afsahi","year":"2023","unstructured":"Afsahi AM, Norbash AM, Syed SF, Sedaghat M, Afsahi G, Shahidi R, Tajabadi Z, Bagherzadeh-Fard M, Karami S, Yarahmadi P, et al. Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis. J Neurol. 2023;270:5131\u201354.","journal-title":"J Neurol"},{"key":"6348_CR2","doi-asserted-by":"crossref","unstructured":"Hawkings MJ, Vaselli NM, Charalampopoulos D, Brierley L, Elliot AJ, Buchan I, Hungerford D. A systematic review of the prevalence of persistent Gastrointestinal symptoms and incidence of new Gastrointestinal illness after acute SARS-CoV-2 infection. Viruses 2023; 15.","DOI":"10.1101\/2023.04.26.23289142"},{"key":"6348_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2020.08.004","volume":"226","author":"S Villapol","year":"2020","unstructured":"Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut Microbiome. Transl Res. 2020;226:57\u201369.","journal-title":"Transl Res"},{"key":"6348_CR4","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","volume":"11","author":"H Peckham","year":"2020","unstructured":"Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, Rosser EC, Webb K, Deakin CT. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11:6317.","journal-title":"Nat Commun"},{"key":"6348_CR5","first-page":"41","volume":"3","author":"DK Twitchell","year":"2022","unstructured":"Twitchell DK, Christensen MB, Hackett G, Morgentaler A, Saad F, Pastuszak AW. Examining male predominance of severe COVID-19 outcomes: A systematic review. Androg Clin Res Ther. 2022;3:41\u201353.","journal-title":"Androg Clin Res Ther"},{"key":"6348_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, et al. Factors associated with COVID-19-related death using opensafely. Nature. 2020;584:430\u20136.","journal-title":"Nature"},{"key":"6348_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239\u201342.","journal-title":"JAMA"},{"key":"6348_CR8","first-page":"257","volume":"17","author":"M Hosseini Largani","year":"2022","unstructured":"Hosseini Largani M, Gorgani F, Abbaszadeh M, Arbabi M, Karimpour Reyhan S, Allameh SF, Shahmansouri N, Parsa S. Depression, anxiety, perceived stress and family support in COVID-19 patients. Iran J Psychiatry. 2022;17:257\u201364.","journal-title":"Iran J Psychiatry"},{"key":"6348_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/10547738211040322","volume":"31","author":"N Yildirim","year":"2022","unstructured":"Yildirim N, Dayilar Candan H, Inan AH. Psychological distress in patients with COVID-19 during hospitalization. Clin Nurs Res. 2022;31:376\u201384.","journal-title":"Clin Nurs Res"},{"key":"6348_CR10","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s40200-020-00667-1","volume":"19","author":"A Zandifar","year":"2020","unstructured":"Zandifar A, Badrfam R, Yazdani S, Arzaghi SM, Rahimi F, Ghasemi S, Khamisabadi S, Mohammadian Khonsari N, Qorbani M. Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19. J Diabetes Metab Disord. 2020;19:1431\u20138.","journal-title":"J Diabetes Metab Disord"},{"key":"6348_CR11","doi-asserted-by":"publisher","first-page":"106512","DOI":"10.1016\/j.rmed.2021.106512","volume":"186","author":"I Saidi","year":"2021","unstructured":"Saidi I, Koumeka PP, Ait Batahar S, Amro L. Factors associated with anxiety and depression among patients with Covid-19. Respir Med. 2021;186:106512.","journal-title":"Respir Med"},{"key":"6348_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s11126-020-09865-9","volume":"92","author":"X Li","year":"2021","unstructured":"Li X, Tian J, Xu Q. The associated factors of anxiety and depressive symptoms in COVID-19 patients hospitalized in Wuhan, China. Psychiatr Q. 2021;92:879\u201387.","journal-title":"Psychiatr Q"},{"key":"6348_CR13","doi-asserted-by":"publisher","first-page":"721532","DOI":"10.3389\/fpsyt.2021.721532","volume":"12","author":"JW Kim","year":"2021","unstructured":"Kim JW, Kang HJ, Jhon M, Ryu S, Lee JY, Kang SJ, Jung SI, Shin IS, Kim SW, Stewart R, Kim JM. Associations between COVID-19 symptoms and psychological distress. Front Psychiatry. 2021;12:721532.","journal-title":"Front Psychiatry"},{"key":"6348_CR14","doi-asserted-by":"crossref","unstructured":"Silva MJA, Ribeiro LR, Gouveia MIM, Marcelino BDR, Santos CSD, Lima KVB, Lima L. Hyperinflammatory response in COVID-19: A systematic review. Viruses 2023; 15.","DOI":"10.3390\/v15020553"},{"key":"6348_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","volume":"40","author":"S Beyerstedt","year":"2021","unstructured":"Beyerstedt S, Casaro EB, Rangel EB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40:905\u201319.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"6348_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5501\/wjv.v12.i2.68","volume":"12","author":"EP Tsounis","year":"2023","unstructured":"Tsounis EP, Triantos C, Konstantakis C, Marangos M, Assimakopoulos SF. Intestinal barrier dysfunction as a key driver of severe COVID-19. World J Virol. 2023;12:68\u201390.","journal-title":"World J Virol"},{"key":"6348_CR17","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3748\/wjg.v29.i15.2283","volume":"29","author":"W Xue","year":"2023","unstructured":"Xue W, Honda M, Hibi T. Mechanisms of Gastrointestinal barrier dysfunction in COVID-19 patients. World J Gastroenterol. 2023;29:2283\u201393.","journal-title":"World J Gastroenterol"},{"key":"6348_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","volume":"184","author":"R Karki","year":"2021","unstructured":"Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi RKS, et al. Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184:149\u2013e168117.","journal-title":"Cell"},{"key":"6348_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2971-8","volume":"588","author":"J Schluter","year":"2020","unstructured":"Schluter J, Peled JU, Taylor BP, Markey KA, Smith M, Taur Y, Niehus R, Staffas A, Dai A, Fontana E, et al. The gut microbiota is associated with immune cell dynamics in humans. Nature. 2020;588:303\u20137.","journal-title":"Nature"},{"key":"6348_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12866-022-02686-9","volume":"22","author":"X Cheng","year":"2022","unstructured":"Cheng X, Zhang Y, Li Y, Wu Q, Wu J, Park SK, Guo C, Lu J. Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases. BMC Microbiol. 2022;22:274.","journal-title":"BMC Microbiol"},{"key":"6348_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41575-022-00698-4","volume":"20","author":"F Zhang","year":"2023","unstructured":"Zhang F, Lau RI, Liu Q, Su Q, Chan FKL, Ng SC. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat Rev Gastroenterol Hepatol. 2023;20:323\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6348_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121\u201341.","journal-title":"Cell"},{"key":"6348_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13054-023-04356-2","volume":"27","author":"M Troseid","year":"2023","unstructured":"Troseid M, Holter JC, Holm K, Vestad B, Sazonova T, Granerud BK, Dyrhol-Riise AM, Holten AR, Tonby K, Kildal AB, et al. Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19. Crit Care. 2023;27:69.","journal-title":"Crit Care"},{"key":"6348_CR24","doi-asserted-by":"publisher","first-page":"102652","DOI":"10.1016\/j.conb.2022.102652","volume":"78","author":"A Ratsika","year":"2023","unstructured":"Ratsika A, Cruz Pereira JS, Lynch CMK, Clarke G, Cryan JF. Microbiota-immune-brain interactions: A lifespan perspective. Curr Opin Neurobiol. 2023;78:102652.","journal-title":"Curr Opin Neurobiol"},{"key":"6348_CR25","doi-asserted-by":"publisher","first-page":"105356","DOI":"10.1016\/j.jff.2022.105356","volume":"99","author":"S Molino","year":"2022","unstructured":"Molino S, Pisarevsky A, Badu S, Wu Q, Mingorance FL, Vega P, Stefanolo JP, Repetti J, Luduena G, Pepa P, et al. Randomized placebo-controlled trial of oral tannin supplementation on COVID-19 symptoms, gut dysbiosis and cytokine response. J Funct Foods. 2022;99:105356.","journal-title":"J Funct Foods"},{"key":"6348_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s13063-021-05281-x","volume":"22","author":"S Molino","year":"2021","unstructured":"Molino S, Pisarevsky A, Mingorance FL, Vega P, Stefanolo JP, Repetti J, Luduena G, Pepa P, Olmos JI, Fermepin MR, et al. Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021;22:310.","journal-title":"Trials"},{"key":"6348_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.medin.2020.12.001","volume":"46","author":"I Huespe","year":"2020","unstructured":"Huespe I, Carboni Bisso I, Di Stefano S, Terrasa S, Gemelli NA, Las Heras M. COVID-19 severity index: A predictive score for hospitalized patients. Med Intensiva (Engl Ed). 2020;46:98\u2013101.","journal-title":"Med Intensiva (Engl Ed)"},{"key":"6348_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.medin.2021.11.002","volume":"47","author":"IA Huespe","year":"2023","unstructured":"Huespe IA, Bisso IC, Roman ES, Prado E, Gemelli N, Sinner J, Heras ML, Risk MR. Multicenter validation of early warning scores for detection of clinical deterioration in COVID-19 hospitalized patients. Med Intensiva. 2023;47:9\u201315.","journal-title":"Med Intensiva"},{"key":"6348_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","volume":"64","author":"K Kroenke","year":"2002","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64:258\u201366.","journal-title":"Psychosom Med"},{"key":"6348_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385\u201396.","journal-title":"J Health Soc Behav"},{"key":"6348_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"6348_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jpainsymman.2019.05.003","volume":"58","author":"KA Hyland","year":"2019","unstructured":"Hyland KA, Hoogland AI, Gonzalez BD, Nelson AM, Lechner S, Tyson DM, Barata A, Gomez MF, Antoni MH, Small B, et al. Evaluation of the psychometric and structural properties of the Spanish version of the hospital anxiety and depression scale in Latina Cancer patients. J Pain Symptom Manage. 2019;58:289\u2013e296282.","journal-title":"J Pain Symptom Manage"},{"key":"6348_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1034\/j.1600-0447.2003.00062.x","volume":"107","author":"JM Quintana","year":"2003","unstructured":"Quintana JM, Padierna A, Esteban C, Arostegui I, Bilbao A, Ruiz I. Evaluation of the psychometric characteristics of the Spanish version of the hospital anxiety and depression scale. Acta Psychiatr Scand. 2003;107:216\u201321.","journal-title":"Acta Psychiatr Scand"},{"key":"6348_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1017\/S1138741600006004","volume":"9","author":"E Remor","year":"2006","unstructured":"Remor E. Psychometric properties of a European Spanish version of the perceived stress scale (PSS). Span J Psychol. 2006;9:86\u201393.","journal-title":"Span J Psychol"},{"key":"6348_CR35","first-page":"345","volume":"38","author":"S Ros Montalban","year":"2010","unstructured":"Ros Montalban S, Comas Vives A, Garcia-Garcia M. Validation of the Spanish version of the PHQ-15 questionnaire for the evaluation of physical symptoms in patients with depression and\/or anxiety disorders: DEPRE-SOMA study. Actas Esp Psiquiatr. 2010;38:345\u201357.","journal-title":"Actas Esp Psiquiatr"},{"key":"6348_CR36","unstructured":"PLC, Dorado ON. [https:\/\/github.com\/nanoporetech\/dorado. Github 2024."},{"key":"6348_CR37","doi-asserted-by":"publisher","first-page":"e978","DOI":"10.1002\/cpz1.978","volume":"4","author":"KD Curry","year":"2024","unstructured":"Curry KD, Soriano S, Nute MG, Villapol S, Dilthey A, Treangen TJ. Microbial community profiling protocol with Full-length 16S rRNA sequences and Emu. Curr Protoc. 2024;4:e978.","journal-title":"Curr Protoc"},{"key":"6348_CR38","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie PJ, Holmes S. Phyloseq: an R package for reproducible interactive analysis and graphics of Microbiome census data. PLoS ONE. 2013;8:e61217.","journal-title":"PLoS ONE"},{"key":"6348_CR39","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/bioinformatics\/bty633","volume":"35","author":"E Paradis","year":"2019","unstructured":"Paradis E, Schliep K. Ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics. 2019;35:526\u20138.","journal-title":"Bioinformatics"},{"issue":"63","key":"6348_CR40","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.21105\/joss.03201","volume":"6","author":"D Barnett","year":"2021","unstructured":"Barnett D, Arts I, Penders J. MicroViz: an R package for Microbiome data visualization and statistics. J Open Source Softw. 2021;6(63):3201.","journal-title":"J Open Source Softw"},{"key":"6348_CR41","doi-asserted-by":"publisher","first-page":"e1004226","DOI":"10.1371\/journal.pcbi.1004226","volume":"11","author":"ZD Kurtz","year":"2015","unstructured":"Kurtz ZD, Muller CL, Miraldi ER, Littman DR, Blaser MJ, Bonneau RA. Sparse and compositionally robust inference of microbial ecological networks. PLoS Comput Biol. 2015;11:e1004226.","journal-title":"PLoS Comput Biol"},{"key":"6348_CR42","unstructured":"Foundation PS. Python 3.12. Python.org. 2024."},{"key":"6348_CR43","unstructured":"CoreR T. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria."},{"key":"6348_CR44","doi-asserted-by":"crossref","unstructured":"Wang Q, Nute M, Treangen TJ: Bakdrive: identifying a minimum set of bacterial species driving interactions across multiple microbial communities. Bioinformatics. 2023; 39:i47-i56.","DOI":"10.1093\/bioinformatics\/btad236"},{"key":"6348_CR45","doi-asserted-by":"crossref","unstructured":"Lin H, Peddada SD: Multigroup analysis of compositions of microbiomes with covariate adjustments and repeated measures. Nat Methods. 2024; 21:83\u201391.","DOI":"10.1038\/s41592-023-02092-7"},{"key":"6348_CR46","doi-asserted-by":"crossref","unstructured":"Huespe I, Carboni Bisso I, Di Stefano S, Terrasa S, Gemelli NA, Las Heras M: COVID-19 Severity Index: A predictive score for hospitalized patients. Med Intensiva (Engl Ed). 2022; 46:98\u2013101.","DOI":"10.1016\/j.medin.2020.12.001"},{"key":"6348_CR47","doi-asserted-by":"crossref","unstructured":"Jung JH, Won JJ, Ko JY: Psychological rehabilitation for isolated patients with COVID-19 infection: A randomized controlled study. PLoS One. 2022; 17:e0278475.","DOI":"10.1371\/journal.pone.0278475"},{"key":"6348_CR48","doi-asserted-by":"crossref","unstructured":"Lee D, Hyun SY, Kim H, Kwak E, Lee S, Baik M, Paik JW, Sim M, Jung SJ: Comparative analysis of mental health impairment among COVID-19 confirmed cases across the pandemic period in South Korea. Asian J Psychiatr. 2024; 101:104233.","DOI":"10.1016\/j.ajp.2024.104233"},{"key":"6348_CR49","doi-asserted-by":"crossref","unstructured":"Wang M, Hu C, Zhao Q, Feng R, Wang Q, Cai H, Guo Z, Xu K, Luo W, Guo C, et al:Acute psychological impact on COVID-19 patients in Hubei: a multicenter observational study. Transl Psychiatry. 2021; 11:133.","DOI":"10.1038\/s41398-021-01259-0"},{"key":"6348_CR50","doi-asserted-by":"crossref","unstructured":"Fernandez-de-Las-Penas C, Rodriguez-Jimenez J, Palacios-Cena M, de-la-Llave-Rincon AI, Fuensalida-Novo S, Florencio LL, Ambite-Quesada S, Ortega-Santiago R, Arias-Buria JL, Liew BXW, et al: Psychometric Properties of the Hospital Anxiety and Depression Scale (HADS) in Previously Hospitalized COVID-19 Patients. Int J Environ Res Public Health. 2022; 19.","DOI":"10.3390\/ijerph19159273"},{"key":"6348_CR51","doi-asserted-by":"crossref","unstructured":"Gupta PK, Singh S, Mahour P, Gupta B, Agarwal M, Dalal PK, Agarwal V, Nischal A, Tripathi A, Himanshu D, et al: Mental health outcome in hospitalized COVID-19 patients: An observational analysis from North Indian tertiary care hospital. Clin Epidemiol Glob Health. 2023; 19:101209.","DOI":"10.1016\/j.cegh.2022.101209"},{"key":"6348_CR52","doi-asserted-by":"crossref","unstructured":"Habibi Asgarabad M, Etesam F, Salehi Yegaei P, Vahabi Z, Akbari Saneh N, Fathi F, Ghosi F, Wiium N: Construct validity of the General Health Questionnaire (GHQ-12) in patients with COVID-19 and its demographic and medical correlates. Front Psychol. 2023; 14:1132154.","DOI":"10.3389\/fpsyg.2023.1333704"},{"key":"6348_CR53","doi-asserted-by":"crossref","unstructured":"Nabi SG, Rashid MU, Sagar SK, Ghosh P, Shahin M, Afroz F, Noor IN, Hossain I,Mondal D, Ahmed HU: Psychological impact of COVID-19 pandemic: A cross-sectional study of hospitalized COVID-19 patients in an urban setting, Bangladesh. Heliyon. 2022; 8:e09110.","DOI":"10.1016\/j.heliyon.2022.e09110"},{"key":"6348_CR54","doi-asserted-by":"crossref","unstructured":"Arabzadeh E, Ebrahimi S, Gholami M, Moiniafshari K, Sohrabi A, Armannia F, Shahba M: The relationship between physical activity pre COVID-19 pandemic with mental health,depression, and anxiety in COVID-19 patients: a cross-sectional study. Sport Sci Health. 2023;1\u20136.","DOI":"10.1007\/s11332-023-01056-w"},{"key":"6348_CR55","doi-asserted-by":"crossref","unstructured":"Hosgoren Alici Y, Cinar G, Hasanli J, Ceran S, Onar D, Gulten E, Akdemir Kalkan I, Memikoglu KO, Celik CO, Devrimci-Ozguven H: Factors associated with progression of depression, anxiety, and stress-related symptoms in outpatients and inpatients with COVID-19: A longitudinal study. Psych J. 2022; 11:550\u2013559.","DOI":"10.1002\/pchj.557"},{"key":"6348_CR56","doi-asserted-by":"crossref","unstructured":"Li T, Zhang L, Cai S, Lu Z, Bao W, Guo Z, Rong S: Association of mental health with clinical outcomes in hospitalized patients with moderate COVID-19. J Affect Disord. 2022; 312:331\u2013336.","DOI":"10.1016\/j.jad.2022.05.047"},{"key":"6348_CR57","doi-asserted-by":"crossref","unstructured":"Thaweerat W, Pongpirul WA, Prasithsirikul W: Assessment of anxiety and depression among hospitalized COVID-19 patients in Thailand during the first wave of the pandemic: a cross-sectional study. Egypt J Neurol Psychiatr Neurosurg. 2021; 57:106.","DOI":"10.1186\/s41983-021-00362-9"},{"key":"6348_CR58","doi-asserted-by":"crossref","unstructured":"Tuna O, Ermis C, Enez Darcin A, Dagistan E, Akkos R, Aksoy UM, Tabak O, Kocatas A: Decreased Functioning and Contents of Worries Associated with Anxiety or Depression Symptom Levels Within Patients Hospitalized with COVID-19 Infection. Psychiatr Danub. 2022; 34:781\u2013789.","DOI":"10.24869\/psyd.2022.781"},{"key":"6348_CR59","unstructured":"Eren N, Zararsiz Y, Medetalibeyoglu A, Polat I: Relationship between Psychological Resilience, Perceived Stress, Death Anxiety and Progression of Disease in Individuals with COVID-19. Noro Psikiyatr Ars. 2023; 60:245\u2013251."},{"key":"6348_CR60","doi-asserted-by":"crossref","unstructured":"Hu Y, Chen Y, Zheng Y, You C, Tan J, Hu L, Zhang Z, Ding L: Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain Behav Immun. 2020; 89:587\u2013593.","DOI":"10.1016\/j.bbi.2020.07.016"},{"key":"6348_CR61","doi-asserted-by":"crossref","unstructured":"Huang Q, Jia M, Sun Y, Jiang B, Cui D, Feng L, Yang W: One-Year Temporal Changes in Long COVID Prevalence and Characteristics: A Systematic Review and Meta-Analysis. Value Health. 2023; 26:934\u2013942.","DOI":"10.1016\/j.jval.2022.11.011"},{"key":"6348_CR62","doi-asserted-by":"crossref","unstructured":"Horn M, Wathelet M, Amad A, Martignene N, Lathiere T, Khelfaoui K, Rousselle M,El Qaoubii O, Vuotto F, Faure K, et al: Persistent physical symptoms after COVID-19 infection and the risk of Somatic Symptom Disorder. J Psychosom Res. 2023; 166:111172.","DOI":"10.1016\/j.jpsychores.2023.111172"},{"key":"6348_CR63","doi-asserted-by":"crossref","unstructured":"Shen Q, Joyce EE, Ebrahimi OV, Didriksen M, Lovik A, Saevarsdottir KS, Magnusdottir I, Mikkelsen DH, Unnarsdottir AB, Hauksdottir A, et al: COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark. Lancet Reg Health Eur. 2023; 35:100756.","DOI":"10.1016\/j.lanepe.2023.100756"},{"key":"6348_CR64","doi-asserted-by":"crossref","unstructured":"Ince FM, Alkan Bilik O, Ince H: Evaluating Mortality Predictors in COVID-19 Intensive Care Unit Patients: Insights into Age, Procalcitonin, Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio,and Ferritin Lactate Index. Diagnostics (Basel). 2024; 14.","DOI":"10.3390\/diagnostics14070684"},{"key":"6348_CR65","doi-asserted-by":"crossref","unstructured":"Queiroz MAF, Neves P, Lima SS, Lopes JDC, Torres M, Vallinoto I, Bichara CDA,Dos Santos EF, de Brito M, da Silva ALS, et al: Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome. Front Cell Infect Microbiol. 2022; 12:922422.","DOI":"10.3389\/fcimb.2022.922422"},{"key":"6348_CR66","doi-asserted-by":"crossref","unstructured":"Hedayati-Ch M, Ebrahim-Saraie HS, Bakhshi A: Clinical and immunological comparison of COVID-19 disease between critical and non-critical courses: a systematic review and meta-analysis. Front Immunol. 2024; 15:1341168.","DOI":"10.3389\/fimmu.2024.1341168"},{"key":"6348_CR67","doi-asserted-by":"crossref","unstructured":"Qin R, He L, Yang Z, Jia N, Chen R, Xie J, Fu W, Chen H, Lin X, Huang R, et al:Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis. Clin Rev Allergy Immunol. 2023; 64:33\u201365.","DOI":"10.1007\/s12016-021-08908-8"},{"key":"6348_CR68","doi-asserted-by":"crossref","unstructured":"Wang J, Jiang M, Chen X, Montaner LJ: Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020; 108:17\u201341.","DOI":"10.1002\/JLB.3COVR0520-272R"},{"key":"6348_CR69","doi-asserted-by":"crossref","unstructured":"Rees K, Aicheler R, Butcher L, Dodd A, Geen J, Lynch C, Massey I, Morris K, Tennant B, Webb R: Seasonal variation in the associations between self-reported long-COVID symptoms and IL-6 signalling-related factors (particularly the rs2228145 variant of the IL-6R gene):A clinical study. Cytokine. 2025; 189:156884.","DOI":"10.1016\/j.cyto.2025.156884"},{"key":"6348_CR70","doi-asserted-by":"crossref","unstructured":"Udomsinprasert W, Jittikoon J, Sangroongruangsri S, Chaikledkaew U: Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha,as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis. J Clin Immunol. 2021; 41:11\u201322.","DOI":"10.1007\/s10875-020-00899-z"},{"key":"6348_CR71","doi-asserted-by":"crossref","unstructured":"Azaiz MB, Jemaa AB, Sellami W, Romdhani C, Ouslati R, Gharsallah H, Ghazouani E, Ferjani M: Deciphering the balance of IL-6\/IL-10 cytokines in severe to critical COVID-19 patients. Immunobiology. 2022; 227:152236.","DOI":"10.1016\/j.imbio.2022.152236"},{"key":"6348_CR72","doi-asserted-by":"crossref","unstructured":"Tjan LH, Furukawa K, Nagano T, Kiriu T, Nishimura M, Arii J, Hino Y, Iwata S,Nishimura Y, Mori Y: Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019. J Infect Dis. 2021; 223:1145\u20131149.","DOI":"10.1093\/infdis\/jiab005"},{"key":"6348_CR73","doi-asserted-by":"crossref","unstructured":"Gebrayel P, Nicco C, Al Khodor S, Bilinski J, Caselli E, Comelli EM, Egert M,Giaroni C, Karpinski TM, Loniewski I, et al: Microbiota medicine: towards clinical revolution. J Transl Med. 2022; 20:111.","DOI":"10.1186\/s12967-022-03296-9"},{"key":"6348_CR74","doi-asserted-by":"crossref","unstructured":"Mostafavi Abdolmaleky H, Zhou JR: Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases. Antioxidants (Basel). 2024; 13.","DOI":"10.3390\/antiox13080985"},{"key":"6348_CR75","doi-asserted-by":"crossref","unstructured":"Butler MI, Bastiaanssen TFS, Long-Smith C, Morkl S, Berding K, Ritz NL, Strain C, Patangia D, Patel S, Stanton C, et al: The gut microbiome in social anxiety disorder: evidence of altered composition and function. Transl Psychiatry. 2023; 13:95.","DOI":"10.1038\/s41398-023-02325-5"},{"key":"6348_CR76","doi-asserted-by":"crossref","unstructured":"Manor O, Dai CL, Kornilov SA, Smith B, Price ND, Lovejoy JC, Gibbons SM, Magis AT: Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020; 11:5206.","DOI":"10.1038\/s41467-020-18871-1"},{"key":"6348_CR77","doi-asserted-by":"crossref","unstructured":"Kim B, Song A, Son A, Shin Y: Gut microbiota and epigenetic choreography: Implications for human health: A review. Medicine (Baltimore). 2024; 103:e39051.","DOI":"10.1097\/MD.0000000000039051"},{"key":"6348_CR78","doi-asserted-by":"crossref","unstructured":"Rogers GB, Keating DJ, Young RL, Wong ML, Licinio J, Wesselingh S: From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry. 2016; 21:738\u2013748.","DOI":"10.1038\/mp.2016.50"},{"key":"6348_CR79","doi-asserted-by":"crossref","unstructured":"Ullah H, Arbab S, Tian Y, Liu CQ, Chen Y, Qijie L, Khan MIU, Hassan IU, Li K:The gut microbiota-brain axis in neurological disorder. Front Neurosci. 2023; 17:1225875.","DOI":"10.3389\/fnins.2023.1225875"},{"key":"6348_CR80","doi-asserted-by":"crossref","unstructured":"Fairbrass KM, Lovatt J, Barberio B, Yuan Y, Gracie DJ, Ford AC: Bidirectional brain-gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut. 2022; 71:1773\u20131780.","DOI":"10.1136\/gutjnl-2021-325985"},{"key":"6348_CR81","doi-asserted-by":"crossref","unstructured":"Gao M, Wang J, Liu P, Tu H, Zhang R, Zhang Y, Sun N, Zhang K: Gut microbiota composition in depressive disorder: a systematic review, meta-analysis,and meta-regression. Transl Psychiatry. 2023; 13:379.","DOI":"10.1038\/s41398-023-02670-5"},{"key":"6348_CR82","doi-asserted-by":"crossref","unstructured":"Nikolova VL, Smith MRB, Hall LJ, Cleare AJ, Stone JM, Young AH: Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis. JAMA Psychiatry. 2021; 78:1343\u20131354.","DOI":"10.1001\/jamapsychiatry.2021.2573"},{"key":"6348_CR83","doi-asserted-by":"crossref","unstructured":"Minichino A, Preston T, Fanshawe JB, Fusar-Poli P, McGuire P, Burnet PWJ, Lennox BR: Psycho-Pharmacomicrobiomics: A Systematic Review and Meta-Analysis. Biol Psychiatry. 2024; 95:611\u2013628.","DOI":"10.1016\/j.biopsych.2023.07.019"},{"key":"6348_CR84","doi-asserted-by":"crossref","unstructured":"Zhao S, Liang S, Tao J, Peng Y, Chen S, Wai HKF, Chung FY, Sin ZY, Wong MKL, Haqq AM, et al: Probiotics for adults with major depressive disorder compared with antidepressants:a systematic review and network meta-analysis. Nutr Rev. 2025; 83:72\u201382.","DOI":"10.1093\/nutrit\/nuad171"},{"key":"6348_CR85","doi-asserted-by":"crossref","unstructured":"Alli SR, Gorbovskaya I, Liu JCW, Kolla NJ, Brown L, Muller DJ: The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies. Int J Mol Sci. 2022; 23.","DOI":"10.3390\/ijms23094494"},{"key":"6348_CR86","doi-asserted-by":"crossref","unstructured":"Ribera C, Sanchez-Orti JV, Clarke G, Marx W, Morkl S, Balanza-Martinez V: Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials. Neurosci Biobehav Rev. 2024; 158:105561.","DOI":"10.1016\/j.neubiorev.2024.105561"},{"key":"6348_CR87","doi-asserted-by":"crossref","unstructured":"Huang X, Fan X, Ying J, Chen S: Emerging trends and research foci in gastrointestinal microbiome. J Transl Med. 2019; 17:67.","DOI":"10.1186\/s12967-019-1810-x"},{"key":"6348_CR88","doi-asserted-by":"crossref","unstructured":"Kaushal A: Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during COVID-19 and other viral infections. J Transl Med. 2024; 22:847.","DOI":"10.1186\/s12967-024-05587-9"},{"key":"6348_CR89","doi-asserted-by":"crossref","unstructured":"Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP,Chen N, et al: Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020; 159:944\u2013955 e948.","DOI":"10.1053\/j.gastro.2020.05.048"},{"key":"6348_CR90","doi-asserted-by":"crossref","unstructured":"Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, Kurilshikov A,Bonder MJ, Valles-Colomer M, Vandeputte D, et al: Population-level analysis of gut microbiome variation. Science. 2016; 352:560\u2013564.","DOI":"10.1126\/science.aad3503"},{"key":"6348_CR91","doi-asserted-by":"crossref","unstructured":"Hazan S, Stollman N, Bozkurt HS, Dave S, Papoutsis AJ, Daniels J, Barrows BD,Quigley EM, Borody TJ: Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity. BMJ Open Gastroenterol. 2022; 9.","DOI":"10.1136\/bmjgast-2022-000871"},{"key":"6348_CR92","doi-asserted-by":"crossref","unstructured":"Wu Y, Cheng X, Jiang G, Tang H, Ming S, Tang L, Lu J, Guo C, Shan H, Huang X:Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes. 2021; 7:61.","DOI":"10.1038\/s41522-021-00232-5"},{"key":"6348_CR93","doi-asserted-by":"crossref","unstructured":"Paczosa MK, Mecsas J: Klebsiella pneumoniae: Going on the Offense with a Strong Defense. Microbiol Mol Biol Rev. 2016; 80:629\u2013661.","DOI":"10.1128\/MMBR.00078-15"},{"key":"6348_CR94","doi-asserted-by":"crossref","unstructured":"Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC, Ng SSS, Zhang F, Li AYL, Lu W, Hui DS,et al: Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022; 71:544\u2013552.","DOI":"10.1136\/gutjnl-2021-325989"},{"key":"6348_CR95","doi-asserted-by":"crossref","unstructured":"Liao C, Rolling T, Djukovic A, Fei T, Mishra V, Liu H, Lindberg C, Dai L, Zhai B, Peled JU, et al: Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes. Nat Microbiol. 2024; 9:1555\u20131565.","DOI":"10.1038\/s41564-024-01680-3"},{"key":"6348_CR96","doi-asserted-by":"crossref","unstructured":"Meng L, Jin H, Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Coskun E, Idil E,Nogaylar R, et al: Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer\u2019s disease. Alzheimers Res Ther. 2024; 16:213.","DOI":"10.1186\/s13195-024-01578-6"},{"key":"6348_CR97","doi-asserted-by":"crossref","unstructured":"Salonen T, Jokinen E, Satokari R, Lahtinen P: Randomized, double-blinded, placebo-controlled pilot study: efficacy of faecal microbiota transplantation on chronic fatigue syndrome. J Transl Med. 2023; 21:513.","DOI":"10.1186\/s12967-023-04227-y"},{"key":"6348_CR98","doi-asserted-by":"crossref","unstructured":"Wu K, Luo Q, Liu Y, Li A, Xia D, Sun X: Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study. J Transl Med. 2024; 22:92.","DOI":"10.1186\/s12967-024-04894-5"},{"key":"6348_CR99","doi-asserted-by":"crossref","unstructured":"Grau-Del Valle C, Fernandez J, Sola E, Montoya-Castilla I, Morillas C, Banuls C: Association between gut microbiota and psychiatric disorders: a systematic review. Front Psychol. 2023; 14:1215674.","DOI":"10.3389\/fpsyg.2023.1215674"},{"key":"6348_CR100","doi-asserted-by":"crossref","unstructured":"Barandouzi ZA, Starkweather AR, Henderson WA, Gyamfi A, Cong XS: Altered Composition of Gut Microbiota in Depression: A Systematic Review. Front Psychiatry. 2020; 11:541.","DOI":"10.3389\/fpsyt.2020.00541"},{"key":"6348_CR101","doi-asserted-by":"crossref","unstructured":"Simpson CA, Diaz-Arteche C, Eliby D, Schwartz OS, Simmons JG, Cowan CSM: The gut microbiota in anxiety and depression - A systematic review. Clin Psychol Rev. 2021; 83:101943.","DOI":"10.1016\/j.cpr.2020.101943"},{"key":"6348_CR102","doi-asserted-by":"crossref","unstructured":"Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S: More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021; 11:16144.","DOI":"10.1038\/s41598-021-95565-8"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06348-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T06:39:41Z","timestamp":1741934381000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06348-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6348"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06348-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.18.24317428","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Hospital de Cl\u00ednicas Jos\u00e9 de San Mart\u00edn (1046-20) following the Argentine Ministry of Health guidelines and the hospital\u2019s treatment protocols. Written informed consent was obtained from all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}